ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today ...
Updated data showed the biotech's approach to the rare lung and liver condition helped restore functional protective proteins ...
Morning Overview on MSN
New DNA base editor cuts bystander edits while keeping efficiency
Researchers have engineered a new class of adenine base editors that reduce unwanted bystander mutations by two to three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results